Target attainment in insulin-naive patients at high risk for hypoglycemia: Results from ACHIEVE Control

•Minimizing the risk of hypoglycemia is important when initiating basal insulin (BI).•ACHIEVE Control evaluated Gla-300 vs standard-of-care first-generation BI (SOC-BI).•We performed a post hoc analysis in patients with ≥1 hypoglycemia risk factor.•Trends generally favored Gla-300 vs SOC-BI for avoiding hypoglycemia.•Results were consistent with the overall ACHIEVE Control population.